DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,747,713 | -77.1% | 6,766 | -77.6% | 0.02% | -76.2% |
| Q2 2022 | $7,643,688 | -23.7% | 30,150 | -11.8% | 0.06% | 0.0% |
| Q1 2022 | $10,021,905 | -75.9% | 34,166 | -72.9% | 0.06% | -74.1% |
| Q4 2021 | $41,542,700 | +317.7% | 126,266 | +286.5% | 0.24% | +237.5% |
| Q3 2021 | $9,944,710 | +93.2% | 32,666 | +70.3% | 0.07% | +125.0% |
| Q2 2021 | $5,148,323 | +10.0% | 19,185 | -7.7% | 0.03% | -22.0% |
| Q1 2021 | $4,679,674 | +146.2% | 20,792 | +143.0% | 0.04% | +173.3% |
| Q4 2020 | $1,900,844 | +2.5% | 8,556 | -0.6% | 0.02% | -28.6% |
| Q3 2020 | $1,854,000 | -70.4% | 8,608 | -75.7% | 0.02% | -71.6% |
| Q2 2020 | $6,258,000 | -54.0% | 35,388 | -64.0% | 0.07% | -51.3% |
| Q1 2020 | $13,615,000 | +567.1% | 98,368 | +639.7% | 0.15% | +913.3% |
| Q4 2019 | $2,041,000 | +127.0% | 13,298 | +113.6% | 0.02% | +114.3% |
| Q3 2019 | $899,000 | +306.8% | 6,227 | +302.5% | 0.01% | +250.0% |
| Q2 2019 | $221,000 | -99.0% | 1,547 | -99.1% | 0.00% | -99.0% |
| Q1 2019 | $23,255,000 | +67.7% | 176,147 | +31.0% | 0.19% | +69.0% |
| Q4 2018 | $13,866,000 | +25.9% | 134,465 | +32.6% | 0.11% | +56.9% |
| Q3 2018 | $11,017,000 | +908.9% | 101,384 | +815.5% | 0.07% | +928.6% |
| Q2 2018 | $1,092,000 | +77.0% | 11,074 | +75.9% | 0.01% | +133.3% |
| Q1 2018 | $617,000 | -86.1% | 6,296 | -86.8% | 0.00% | -85.7% |
| Q4 2017 | $4,425,000 | -73.4% | 47,667 | -75.4% | 0.02% | -80.9% |
| Q3 2017 | $16,649,000 | +35.9% | 194,086 | +33.7% | 0.11% | +34.1% |
| Q2 2017 | $12,249,000 | +228.0% | 145,142 | +232.5% | 0.08% | +192.9% |
| Q1 2017 | $3,734,000 | -66.0% | 43,658 | -69.1% | 0.03% | -54.8% |
| Q4 2016 | $10,984,000 | -7.3% | 141,106 | -6.7% | 0.06% | +1.6% |
| Q3 2016 | $11,850,000 | -33.4% | 151,160 | -14.2% | 0.06% | -24.7% |
| Q2 2016 | $17,795,000 | +2711.2% | 176,189 | +2539.5% | 0.08% | +1925.0% |
| Q1 2016 | $633,000 | -93.7% | 6,675 | -93.8% | 0.00% | -93.0% |
| Q4 2015 | $10,057,000 | +1567.8% | 108,278 | +1430.9% | 0.06% | +1800.0% |
| Q3 2015 | $603,000 | -99.7% | 7,073 | -99.7% | 0.00% | -99.7% |
| Q2 2015 | $198,648,000 | +43.4% | 2,320,920 | +42.3% | 1.03% | +32.6% |
| Q1 2015 | $138,513,000 | +35.6% | 1,631,484 | +36.9% | 0.77% | +29.0% |
| Q4 2014 | $102,165,000 | -8.2% | 1,191,985 | -18.6% | 0.60% | -21.1% |
| Q3 2014 | $111,241,000 | -31.1% | 1,464,089 | -28.6% | 0.76% | -44.3% |
| Q2 2014 | $161,509,000 | +14230.9% | 2,051,430 | +13552.5% | 1.36% | +12300.0% |
| Q1 2014 | $1,127,000 | +62.9% | 15,026 | +67.5% | 0.01% | +175.0% |
| Q4 2013 | $692,000 | -69.4% | 8,969 | -74.9% | 0.00% | -83.3% |
| Q2 2013 | $2,264,000 | – | 35,761 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |